Active Stocks

Thu Jun 11 2026 12:47:15

ICICI Bank share price
1,331.70 2.97%

Eternal share price
236.50 -1.29%

HDFC Bank share price
752.10 0.68%

Power Grid Corporation of India share price
287.75 0.17%

NTPC share price
351.95 0.10%

Business News > Mint Authors > Ravi Ananthanarayanan

Ravi Ananthanarayanan

ARTICLES BY RAVI ANANTHANARAYANAN

Dilip Shanghvi, founder and managing director of Sun Pharma. Photo: Mint

A rocky road to redemption for Dilip Shanghvi’s Sun Pharma

3 min read . 05 Dec 2018

An increase in sugar cane prices would have upset the delicate balance achieved in managing the interests of farmers and mills. Photo: Reuters

No hike in Uttar Pradesh sugar cane price a blessing

2 min read . 03 Dec 2018

Hindustan Unilever is likely to be the vehicle for Unilever’s Horlicks acquisition from GSK Consumer. Photo: Ramesh Pathania/Mint

Why Hindustan Unilever wants a taste of Horlicks

2 min read . 29 Nov 2018

China’s economy is showing signs of a slowdown and weakness in demand in the global automotive market is also a red flag for steel demand. Graphic: Mint

Declining metal prices a risk for Indian producers

2 min read . 28 Nov 2018

The increase in crude oil prices was a budding thorn in the side of FMCG companies. Graphic: Mint

FMCG stocks back in favour as costs beat a retreat

2 min read . 27 Nov 2018

The September quarter saw smaller FMCG companies growing at 38% versus 15% for the national firms.

Smaller FMCG firms race ahead, put bigger rivals on notice

2 min read . 26 Nov 2018

Dr Reddy’s shares have outperformed peers in recent years. Graphic: Subrata Jana/Mint

Dr Reddy’s gets a Suboxone boost

2 min read . 23 Nov 2018

India’s sugar production in 2018 is expected to touch 28.9 million tonnes—that’s 6 million tonnes lower than the initial industry estimate. Graphic: Mint

Sugar: Lower output is good for prices but can turn into risk

2 min read . 12 Nov 2018

Graphic: Naveen Kumar Saini/Mint

Cipla: A perfect storm in one quarter

2 min read . 07 Nov 2018

The completion of the Aleris acquisition by Hindalco’s US arm Novelis is a key event to watch out for. Graphic: Mint

Q2 results: Hindalco’s domestic outlook hinges on foreign actors

2 min read . 05 Nov 2018

The bottles of Parachute coconut oil that Marico sells alone contribute 36% to its revenues. Graphic: Mint

Marico Q2 results: Getting off the inflation tiger

3 min read . 02 Nov 2018

Lupin has mimicked the BSE Healthcare index so far this fiscal year. Photo: Bloomberg

Lupin’s Q2 results offers hope of a revival

1 min read . 01 Nov 2018

In the September quarter, Colgate’s sales volumes rose by 7% over the year-ago quarter, when the GST rollout had caused a decline of 0.9%. Graphic: Mint

Colgate sails steady in Q2 as Patanjali is now a distant memory

2 min read . 30 Oct 2018

With the cigarette business has stabilized to some extent, ITC’s FMCG sales growth too looks healthy but margins remain a question mark. Graphic: Mint

ITC Q2 results 2018-19: Smoke signals don’t bring good news

2 min read . 29 Oct 2018

JSW Steel Ltd’s consolidated revenue rose by 25% from a year ago to ₹21,552 crore and increased by 5% sequentially.

JSW: Despite signs of stability, rising costs pose a risk to margins

2 min read . 26 Oct 2018

The Zydus-Kraft Heinz deal is indicative of the growth challenges in India’s energy drinks market. Graphic: Mint

The message for the Horlicks maker in the Complan deal

2 min read . 25 Oct 2018

Lower volumes and metal prices affected Hindustan Zinc’s performance in the September quarter. Graphic: Mint

Hindustan Zinc dividend payout offsets dull Q2 results

2 min read . 23 Oct 2018

ArcelorMittal will own Essar Steel in a joint venture with Nippon Steel and Sumitomo Metal—an arrangement that will lower its financial burden. Photo: Reuters

ArcelorMittal’s Essar Steel acquisition: Who wins, who loses

3 min read . 22 Oct 2018

India’s rising steel demand is making companies starry-eyed

2 min read . 18 Oct 2018

Monday’s announcement will see Dr. Reddy’s API facility in Hyderabad sold to Therapiva Pvt. Ltd, a JV between a subsidiary of Neopharma Llc (parent of Neopharma Inc.) and Laxai Life Sciences. Photo: Mint

Dr Reddy’s: API unit sale should lower costs, may not be a windfall

2 min read . 16 Oct 2018